The administration of hydroxychloroquine, a drug against malaria, has neither improved nor deteriorated significantly the state of critically ill patients for the coronavirus, according to a study released Thursday and conducted in hospitals in new york city.

" The risk of intubation or death was not significantly greater or lesser among patients who received hydroxychloroquine as among those having received nothing ", according to the authors of the study published in the New England Journal of Medicine.